FLT3 and acute myeloid leukemia: In the present study, we demonstrated that CG-806 has a superior anti-leukemia efficacy especially against AML harboring “gatekeeper” F691 mutations or FLT3 WT compared to other FLT3i, without detectable toxicity in normal BM samples.